1054 related articles for article (PubMed ID: 21772280)
1. Inflammation meets cancer, with NF-κB as the matchmaker.
Ben-Neriah Y; Karin M
Nat Immunol; 2011 Jul; 12(8):715-23. PubMed ID: 21772280
[TBL] [Abstract][Full Text] [Related]
2. The non-canonical NF-κB pathway in immunity and inflammation.
Sun SC
Nat Rev Immunol; 2017 Sep; 17(9):545-558. PubMed ID: 28580957
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB: linking inflammation and immunity to cancer development and progression.
Karin M; Greten FR
Nat Rev Immunol; 2005 Oct; 5(10):749-59. PubMed ID: 16175180
[TBL] [Abstract][Full Text] [Related]
4. NF-κB, inflammation, immunity and cancer: coming of age.
Taniguchi K; Karin M
Nat Rev Immunol; 2018 May; 18(5):309-324. PubMed ID: 29379212
[TBL] [Abstract][Full Text] [Related]
5. NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration.
Dorrington MG; Fraser IDC
Front Immunol; 2019; 10():705. PubMed ID: 31024544
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PD-L1 Expression by NF-κB in Cancer.
Antonangeli F; Natalini A; Garassino MC; Sica A; Santoni A; Di Rosa F
Front Immunol; 2020; 11():584626. PubMed ID: 33324403
[TBL] [Abstract][Full Text] [Related]
7. New regulators of NF-kappaB in inflammation.
Ghosh S; Hayden MS
Nat Rev Immunol; 2008 Nov; 8(11):837-48. PubMed ID: 18927578
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factor NF-κB: An Update on Intervention Strategies.
Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
[TBL] [Abstract][Full Text] [Related]
9. NF-κB and innate immunity in ischemic stroke.
Harari OA; Liao JK
Ann N Y Acad Sci; 2010 Oct; 1207():32-40. PubMed ID: 20955423
[TBL] [Abstract][Full Text] [Related]
10. Regulation of NF-κB by deubiquitinases.
Harhaj EW; Dixit VM
Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
[TBL] [Abstract][Full Text] [Related]
11. NF-κB is 25.
Baltimore D
Nat Immunol; 2011 Jul; 12(8):683-5. PubMed ID: 21772275
[No Abstract] [Full Text] [Related]
12. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
Freitas RHCN; Fraga CAM
Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
[TBL] [Abstract][Full Text] [Related]
13. Cancer secretome and inflammation: The bright and the dark sides of NF-κB.
Capece D; Verzella D; Tessitore A; Alesse E; Capalbo C; Zazzeroni F
Semin Cell Dev Biol; 2018 Jun; 78():51-61. PubMed ID: 28779979
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-κB in immunity and inflammation: the Treg and Th17 connection.
Ruan Q; Chen YH
Adv Exp Med Biol; 2012; 946():207-21. PubMed ID: 21948370
[TBL] [Abstract][Full Text] [Related]
15. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
Uwe S
Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Factor κB (NF-κB)-Mediated Inflammation in Multiple Sclerosis.
Zhou Y; Cui C; Ma X; Luo W; Zheng SG; Qiu W
Front Immunol; 2020; 11():391. PubMed ID: 32265906
[TBL] [Abstract][Full Text] [Related]
18. β2-Adrenergic receptors in immunity and inflammation: stressing NF-κB.
Kolmus K; Tavernier J; Gerlo S
Brain Behav Immun; 2015 Mar; 45():297-310. PubMed ID: 25459102
[TBL] [Abstract][Full Text] [Related]
19. Role of NF-kappaB in immune and inflammatory responses in the gut.
Neurath MF; Becker C; Barbulescu K
Gut; 1998 Dec; 43(6):856-60. PubMed ID: 9824616
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB in liver diseases: a target for drug therapy.
Muriel P
J Appl Toxicol; 2009 Mar; 29(2):91-100. PubMed ID: 18937212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
